Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PTTG1 pseudogene 1 (PTTG1P1) is a pseudogene associated with the PTTG1 gene family, but it does not code for a functional protein and is not itself a recognized therapeutic target, receptor, enzyme, or other direct molecular target. The major PTTG gene family members are PTTG1 and PTTG2 (protein-coding) and PTTG3P (pseudogene, also referred to sometimes as PTTG3 pseudogene), but there is limited or no information available on a pseudogene specifically denoted "PTTG1P1" in major biomedical databases and review articles. There is a high likelihood that "PTTG1P1" refers either to a mislabeling, a non-coding pseudogene without clinical or experimental significance, or a rarely annotated variant not recognized as a canonical therapeutic target. Available literature focuses on PTTG1, PTTG2, and PTTG3P as the functionally relevant members in cancer and cell division[1][2][3][4][5]. Key point: "PTTG1 pseudogene 1" (PTTG1P1) is not listed as a protein-coding gene or as a therapeutic target in current authoritative references, and searches for PTTG1P1 do not yield entries corresponding to a distinct, studied molecule relevant for pharmacology or disease modulation[3]. Interpretation: - This name is most likely an error, a rarely-used alias, or a misannotation for a non-coding region related to PTTG1. - If you need target information for the PTTG1 protein (pituitary tumor-transforming gene 1, a recognized oncogene), that would warrant a different, well-annotated target entry. - For known pseudogenes of PTTG1, current major literature only recognizes PTTG3P[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PTTG1 pseudogene 1 (PTTG1P1).